ArticleBlood cancer journal2025

From response to cure: Unaddressed clinical challenges in the Tali-cel™ CD19 CAR-T trial for relapsed/refractory pediatric B-cell acute lymphoblastic leukemia.

Zhao Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.